PPH Fail-to-Deliver
VanEck Pharmaceutical ETF (PPH) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $603.0M, listed on NASDAQ, carrying a beta of 0.46 to the broader market. VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals. public since 2000-02-01.
Fail-to-deliver (FTD) data from the SEC tracks settlement failures where shares were not delivered within the standard settlement period. Persistent FTDs may indicate naked short selling or settlement issues and are monitored by regulators.
- Latest Date
- 2026-04-29
- Latest FTD Quantity
- 3
- Latest Price
- $99.73
- 30-Day Avg FTD
- 21.3K
- 30-Day Total FTD
- 640.3K
Showing 30 days of SEC fail-to-deliver data for VanEck Pharmaceutical ETF.
Learn how fails-to-deliver is reported and how to read the data →
Frequently asked PPH fail to deliver questions
- What is the latest PPH fail-to-deliver count?
- As of Apr 29, 2026, VanEck Pharmaceutical ETF (PPH) fail-to-deliver quantity is 3 shares, with a 30-day average of 21.3K shares. The SEC publishes FTD data twice monthly: first-half data at month-end, second-half around the 15th of the following month.
- What is the FTD aggregate net balance?
- FTD figures represent the aggregate net balance in NSCC's Continuous Net Settlement (CNS) system, not the gross failed-share count. The published numbers run 2-6 weeks stale relative to the underlying settlement date.
- How do PPH FTDs affect options pricing?
- Persistent FTDs flag hard-to-borrow conditions that distort put-call parity: in HTB names, synthetic long stock (long call + short put at the same strike) trades below the frictionless-parity price by approximately the borrow rebate. The discount equals the lending revenue forgone by holding the synthetic instead of actual shares. Reg SHO threshold-list inclusion follows from sustained FTD persistence.